Benazepril contraindications: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) m (Changed protection level for "Benazepril contraindications" ([Edit=Allow only autoconfirmed users] (expires 20:12, 18 February 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 20:12, 18 February 2014 (UTC)))) |
Amr Marawan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Benazepril}} | {{Benazepril}} | ||
{{CMG}} | {{CMG}} ; {{AE}} {{AM}} | ||
==Contraindications== | ==Contraindications== | ||
Lotensin is contraindicated in patients who are [[hypersensitive]] to benazapril or to any other ACE inhibitor. | Lotensin is contraindicated in patients who are [[hypersensitive]] to benazapril or to any other [[ACE inhibitor]]. | ||
Lotensin is also contraindicated in patients with a history of [[angioedema]] with or without previous [[ACE inhibitor]] treatment.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LOTENSIN (BENAZEPRIL HYDROCHLORIDE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d954024-a191-46e3-ba71-2a7d5b0c65d5#nlm34067-9 | publisher = | date = | accessdate = }}</ref> | Lotensin is also contraindicated in patients with a history of [[angioedema]] with or without previous [[ACE inhibitor]] treatment.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LOTENSIN (BENAZEPRIL HYDROCHLORIDE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d954024-a191-46e3-ba71-2a7d5b0c65d5#nlm34067-9 | publisher = | date = | accessdate = }}</ref> | ||
Revision as of 20:13, 11 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2]
Contraindications
Lotensin is contraindicated in patients who are hypersensitive to benazapril or to any other ACE inhibitor.
Lotensin is also contraindicated in patients with a history of angioedema with or without previous ACE inhibitor treatment.[1]
References
Adapted from the FDA Package Insert.